Virtu Financial’s Avidity Biosciences RNAM Stock Holding History

Virtu Financial’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,575	Closed	-$1.56M	–	2204
2025 Q4	$1.56M	Buy	+21,575	New	+$1.39M	0.06%	218
2025 Q1	–	Sell	-7,219	Closed	-$210K	–	1940
2024 Q4	$210K	Buy	+7,219	New	+$302K	0.01%	859
2022 Q4	–	Sell	-18,252	Closed	-$298K	–	2061
2022 Q3	$298K	Buy	18,252 +1,875	+11%	+$35.9K	0.03%	649
2022 Q2	$238K	Buy	+16,377	New	+$244K	0.02%	686

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Virtu Financial's RNAM Position: Q1 2026 in Review

Virtu Financial sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 21,575 shares — an estimated $1.56M sold.

Virtu Financial first reported a position in RNAM in Q2 2022 and held it in 4 quarters. The position peaked at $1.56M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Virtu Financial reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 21,575 Avidity Biosciences shares in Q1 2026, an estimated $1.56M.
Virtu Financial first reported a position in Avidity Biosciences in Q2 2022 and held it in 4 quarters.
Virtu Financial's Avidity Biosciences position peaked at $1.56M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.